Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Circulating platelet-progenitor cell coaggregate formation is increased in patients with acute coronary syndromes and augments recruitment of CD34+ cells in the ischaemic microcirculation.

Stellos K, Bigalke B, Borst O, Pfaff F, Elskamp A, Sachsenmaier S, Zachmann R, Stamatelopoulos K, Schönberger T, Geisler T, Langer H, Gawaz M.

Eur Heart J. 2013 Aug;34(32):2548-56. doi: 10.1093/eurheartj/eht131. Epub 2013 Apr 17.

PMID:
23594593
2.

Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells.

Stellos K, Bigalke B, Langer H, Geisler T, Schad A, Kögel A, Pfaff F, Stakos D, Seizer P, Müller I, Htun P, Lindemann S, Gawaz M.

Eur Heart J. 2009 Mar;30(5):584-93. doi: 10.1093/eurheartj/ehn566. Epub 2008 Dec 24.

PMID:
19109356
3.

Enhanced mobilization of CD34(+) progenitor cells expressing cell adhesion molecules in patients with STEMI.

Brehm M, Ebner P, Picard F, Urbien R, Turan G, Strauer BE.

Clin Res Cardiol. 2009 Aug;98(8):477-86. doi: 10.1007/s00392-009-0021-5. Epub 2009 May 29.

PMID:
19479183
4.

Junctional adhesion molecule A expressed on human CD34+ cells promotes adhesion on vascular wall and differentiation into endothelial progenitor cells.

Stellos K, Langer H, Gnerlich S, Panagiota V, Paul A, Schönberger T, Ninci E, Menzel D, Mueller I, Bigalke B, Geisler T, Bültmann A, Lindemann S, Gawaz M.

Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1127-36. doi: 10.1161/ATVBAHA.110.204370. Epub 2010 Apr 8.

5.

Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes.

Montoro-García S, Shantsila E, Tapp LD, López-Cuenca A, Romero AI, Hernández-Romero D, Orenes-Piñero E, Manzano-Fernández S, Valdés M, Marín F, Lip GY.

Atherosclerosis. 2013 Apr;227(2):313-22. doi: 10.1016/j.atherosclerosis.2013.01.028. Epub 2013 Jan 29.

PMID:
23415055
6.

Persistent enhanced platelet activation in patients with acute myocardial infarction and coronary microvascular obstruction: clinical implications.

Aurigemma C, Scalone G, Tomai F, Altamura L, De Persio G, Stazi A, Lanza GA, Crea F.

Thromb Haemost. 2014 Jan;111(1):122-30. doi: 10.1160/TH13-02-0166. Epub 2013 Oct 2.

PMID:
24085158
7.

Vessel repair: do progenitor cells hitchhike a piggyback ride?

Vasa-Nicotera M, Nickenig G.

Eur Heart J. 2013 Aug;34(32):2501-3. doi: 10.1093/eurheartj/eht198. Epub 2013 Jun 26. No abstract available.

PMID:
23804586
8.

Circulating CD34⁺ progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris.

Grøgaard HK, Solheim S, Landsverk KS, Seljeflot I, Hoffmann P, Arnesen H, Ilebekk A.

Scand J Clin Lab Invest. 2011 Jul;71(4):322-9. doi: 10.3109/00365513.2011.565367. Epub 2011 Apr 4.

PMID:
21463159
9.

Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction.

Wojakowski W, Tendera M, Michałowska A, Majka M, Kucia M, Maślankiewicz K, Wyderka R, Ochała A, Ratajczak MZ.

Circulation. 2004 Nov 16;110(20):3213-20. Epub 2004 Nov 8.

10.

Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation.

Stępień E, Stankiewicz E, Zalewski J, Godlewski J, Zmudka K, Wybrańska I.

Arch Med Res. 2012 Jan;43(1):31-5. doi: 10.1016/j.arcmed.2012.01.006. Epub 2012 Feb 2.

PMID:
22306248
11.

Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells.

Stellos K, Langer H, Daub K, Schoenberger T, Gauss A, Geisler T, Bigalke B, Mueller I, Schumm M, Schaefer I, Seizer P, Kraemer BF, Siegel-Axel D, May AE, Lindemann S, Gawaz M.

Circulation. 2008 Jan 15;117(2):206-15. Epub 2007 Dec 17.

13.

Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.

Czyz A, Kołacz E, Angerer D, Zawilska K.

Kardiol Pol. 2005 Mar;62(3):189-200; discussion 201. English, Polish.

PMID:
15830013
14.

Platelet expression of transforming growth factor beta 1 is enhanced and associated with cardiovascular prognosis in patients with acute coronary syndrome.

Rath D, Chatterjee M, Müller I, Müller K, Böckmann C, Droppa M, Stimpfle F, Karathanos A, Borst O, Seizer P, Langer H, Schwab M, Gawaz M, Geisler T.

Atherosclerosis. 2014 Dec;237(2):754-9. doi: 10.1016/j.atherosclerosis.2014.10.021. Epub 2014 Oct 30.

PMID:
25463116
15.

Binding of oxidized low-density lipoprotein on circulating platelets is increased in patients with acute coronary syndromes and induces platelet adhesion to vascular wall in vivo--brief report.

Stellos K, Sauter R, Fahrleitner M, Grimm J, Stakos D, Emschermann F, Panagiota V, Gnerlich S, Perk A, Schönberger T, Bigalke B, Langer HF, Gawaz M.

Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):2017-20. doi: 10.1161/ATVBAHA.111.244707. Epub 2012 Jun 14.

16.

Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction.

Ault KA, Cannon CP, Mitchell J, McCahan J, Tracy RP, Novotny WF, Reimann JD, Braunwald E.

J Am Coll Cardiol. 1999 Mar;33(3):634-9.

17.

Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial.

Romppanen H, Nammas W, Kervinen K, Mikkelsson J, Pietilä M, Lalmand J, Rivero-Crespo F, Pentikäinen M, Tedjokusumo P, Karjalainen PP.

Minerva Cardioangiol. 2013 Apr;61(2):201-9.

PMID:
23492603
18.

Impact of depression on circulating endothelial progenitor cells in patients with acute coronary syndromes: a pilot study.

Di Stefano R, Felice F, Pini S, Mazzotta G, Bovenzi FM, Bertoli D, Abelli M, Borelli L, Cardini A, Lari L, Gesi C, Muccignat A, Oligeri C, Michi P, Balbarini A.

J Cardiovasc Med (Hagerstown). 2014 Apr;15(4):353-9. doi: 10.2459/JCM.0b013e328365c195.

PMID:
24685963
19.

Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct.

Pasquet S, Sovalat H, Hénon P, Bischoff N, Arkam Y, Ojeda-Uribe M, Bouar Rl, Rimelen V, Brink I, Dallemand R, Monassier JP.

Cytotherapy. 2009;11(8):1002-15. doi: 10.3109/14653240903164963.

PMID:
19929464
20.

The clinical importance of laboratory-defined aspirin resistance in patients presenting with non-ST elevation acute coronary syndromes.

Acikel S, Yildirir A, Aydinalp A, Bal U, Kaynar G, Ozin B, Muderrisoglu H.

Blood Coagul Fibrinolysis. 2009 Sep;20(6):427-32. doi: 10.1097/MBC.0b013e32832c87b3.

PMID:
19542882

Supplemental Content

Support Center